Review
Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw
Affiliations
- PMID: 16366043
Item in Clipboard
Review
Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw
Gen Dent.
2005 Nov-Dec.
No abstract available
Similar articles
-
Bisphosphonates and osteonecrosis of the jaws: science and rationale.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Aug;104(2):186-93. doi: 10.1016/j.tripleo.2006.12.004. Epub 2007 Apr 20. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007. PMID: 17448709 Review.
-
Bisphosphonates: a potential threat to your patients.J Indiana Dent Assoc. 2005-2006 Winter;84(4):4-9. J Indiana Dent Assoc. 2005. PMID: 16605211 No abstract available.
-
Bisphosphonates and osteonecrosis of the jaws.J Dent Educ. 2008 Aug;72(8):919-29. J Dent Educ. 2008. PMID: 18676801 Review.
-
Bisphosphonates--role in cancer therapies.J Oral Maxillofac Surg. 2009 May;67(5 Suppl):19-26. doi: 10.1016/j.joms.2009.01.012. J Oral Maxillofac Surg. 2009. PMID: 19371811 Review. No abstract available.
-
Treating osteonecrosis.Br Dent J. 2006 Mar 11;200(5):242-3. doi: 10.1038/sj.bdj.4813366. Br Dent J. 2006. PMID: 16528300 No abstract available.
Cited by
-
Effect of low-level laser therapy and zoledronic acid on bone repair process.Lasers Med Sci. 2019 Aug;34(6):1081-1088. doi: 10.1007/s10103-019-02810-8. Epub 2019 Jun 1. Lasers Med Sci. 2019. PMID: 31154596
-
Denosumab: a new agent in the management of hypercalcemia of malignancy.Future Oncol. 2015;11(21):2865-71. doi: 10.2217/fon.15.232. Epub 2015 Sep 25. Future Oncol. 2015. PMID: 26403973 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical